Insights from assessment for arrhythmia after CoViD-19 vaccination among Indians

HOME | PDF |

Title	Insights from assessment for arrhythmia after CoViD-19 vaccination among Indians
Authors	S. Sunita¹, Madhu Bala Negi², Moti Lal³, Chandan Kumar^{*, 1} & Manish Kumar¹
Affiliation	¹Department of Physiology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India; ²Department of Medicine, ABVIMS, New Delhi, India; ³Lady Hardinge Medical College, New Delhi, India; *Corresponding author
Email	S Sunita - E-mail: dr.sunitaigims@gmail.com Madhu Bala Negi - E-mail: madhu.negi2007@gmail.com Moti Lal - E-mail: motilalnegi@gmail.com Chandan Kumar - E-mail: dr.chandankumar2010@gmail.com Manish Kumar - E-mail: krmanish77@gmail.com
Article Type	Research Article
Date	Received May 1, 2024; Revised May 31, 2024; Accepted May 31, 2024, Published May 31, 2024
Abstract	Post-vaccination myocarditis is usually moderate and transient, recovering quickly with conservative treatment. Therefore, it is of interest to assess for arrhythmia after CoViD-19 vaccination among Indians. We looked for ECG abnormalities in a small cohort of 50 participants after 52 weeks after receiving the Oxford/AstraZeneca CoViD-19 vaccination. Data shows that post-vaccination myocarditis is typically mild and transient, with most cases resolving swiftly through conservative management. Thus, it is unlikely that this vaccine will induce severe arrhythmias or life-threatening cardiac events in the general population.
Keywords	ECG, Covieshield vaccine, myocarditis, arrhythmia.
Citation	Sunita et al. Bioinformation 20(5): 430-433 (2024)
Edited by	Vini Mehta
ISSN	0973-2063
Publisher	Biomedical Informatics
License	This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.